Large-scale testing (Phase 3)UnknownNCT01352091What this trial is testingAdjuvant AI Combined With ZoladexWho this might be right forBreast Cancer Fudan University 670
Testing effectiveness (Phase 2)UnknownNCT01266213What this trial is testingFulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenWho this might be right forMetastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal Samsung Medical Center 147
Not applicableStudy completedNCT03779217What this trial is testingBreast Disease and Cardiovascular DiseaseWho this might be right forCardiovascular DiseasesIschemic Heart Disease University of Campania Luigi Vanvitelli 10,000
Large-scale testing (Phase 3)UnknownNCT05620355What this trial is testingEfficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.Who this might be right forUterine FibroidsHeavy Menstrual Bleeding Bio Genuine (Shanghai) Biotech Co., Ltd. 312
Testing effectiveness (Phase 2)Looking for participantsNCT07159451What this trial is testingA Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 140
Testing effectiveness (Phase 2)Study completedNCT01857596What this trial is testingPhase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and SafetyWho this might be right forHypoactive Sexual Desire Disorder (DSM-IV-TR Defined)Sexual Interest/Arousal Disorder (DSM-5 Defined) S1 Biopharma, Inc. 30
Large-scale testing (Phase 3)Study completedNCT05950841What this trial is testingSafety and Effectiveness of IHAT in Iron Deficient Pre-menopausal WomanWho this might be right forIron-deficiency RDC Clinical Pty Ltd 180
Not applicableUnknownNCT04891731What this trial is testingEfficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast CancerWho this might be right forHormone Receptor-positive Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Study completedNCT02049866What this trial is testingDenosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOPWho this might be right forAdult Idiopathic Generalized Osteoporosis Elizabeth Shane 33
Not applicableActive Not RecruitingNCT03448003What this trial is testingComprehensive Lifestyle Change To Prevent Breast CancerWho this might be right forPremenopausal M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT02175394What this trial is testingEffect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal SubjectsWho this might be right forHealthy Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT05745870What this trial is testingCreatine Supplementation and Resistance Training in Premenopausal FemalesWho this might be right forHealth Behavior University of Idaho 27
Large-scale testing (Phase 3)UnknownNCT04753177What this trial is testingThe Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast CancerWho this might be right forThe Neoadjuvant Therapy Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Large-scale testing (Phase 3)Study completedNCT00311636What this trial is testingTriptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryWho this might be right forBreast Cancer Gruppo Italiano Mammella (GIM) 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287098What this trial is testingImlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 600
Testing effectiveness (Phase 2)Study completedNCT00004400What this trial is testingPhase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive WomenWho this might be right forHIV InfectionsCachexia Charles Drew University of Medicine and Science 56
Large-scale testing (Phase 3)Ended earlyNCT00853567What this trial is testingEvaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine FibroidsWho this might be right forUterine Fibroids Repros Therapeutics Inc. 71
Not applicableStudy completedNCT06689813What this trial is testingEffect of Vitamin D Supplementation on Severity of Stress Urinary Incontinence in Premenopausal Women With Vitamin D InsufficiencyWho this might be right forStress Urinary Incontinence Shalamar Institute of Health Sciences 86
Not applicableUnknownNCT02247323What this trial is testingOvarian Malignancy Incidence in Moderate Risk Women With Low CA 125Who this might be right forOvarian Cancer Beni-Suef University 200
Large-scale testing (Phase 3)Study completedNCT06009627What this trial is testingStudy of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer PatientsWho this might be right forBreast Cancer Tianjin Medical University Cancer Institute and Hospital 119